A treatment system for implementing an extracorporeal liver assist device

Area of Science:

• Biotechnology
• Medical Devices
• Regenerative Medicine

Background:

• Biologically active devices are crucial for managing endocrine pancreatic failure (diabetes) and acute liver failure.
• Current mechanical devices fail to fully replace organ function, leading to severe health consequences.
• Existing extracorporeal blood treatment systems are inadequate for delivering high molecular weight substances and meeting device metabolic needs.

Purpose of the Study:

• To develop an improved extracorporeal system for biologically active devices.
• To address the limitations of current blood treatment systems in supporting organ function.
• To enable safe, continuous perfusion for extracorporeal organs, particularly for liver assist devices.

Main Methods:

• Development of a novel extracorporeal blood treatment system.
• Design focused on safe and continuous perfusion of extracorporeal organs.
• Evaluation of the system's suitability for delivering high molecular weight substances and supporting metabolic needs.

Main Results:

• A new system was designed to overcome the limitations of existing extracorporeal technologies.
• The system provides safe and continuous perfusion for extracorporeal organs.
• The design addresses the metabolic requirements of biologically active devices.

Conclusions:

• The developed system is suitable for supporting biologically active devices, such as cell-based liver assist systems.
• This innovation represents a significant advancement in extracorporeal organ support.
• The system's design paves the way for improved management of conditions like diabetes and liver failure.